<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2022.8347</article-id>
<article-id pub-id-type="publisher-id">OR-0-0-08347</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>microRNA-485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Lyu</surname><given-names>Xueman</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ling</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Lu</surname><given-names>Jia</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hong</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lina</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>08</month>
<year>2022</year></pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>06</month>
<year>2022</year></pub-date>
<volume>48</volume>
<issue>2</issue>
<elocation-id>136</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Lyu et al.</copyright-statement>
<copyright-year>2022</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 41: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="41" page="3137" id="RA1" xlink:href="10.3892/or.2019.7061" ext-link-type="doi">3137&#x2013;3147</related-article>, 2019; DOI: 10.3892/or.2019.7061</p>
<p>Following the publication of the above paper, the authors submitted a request to the Editorial Office to retract the article on account of the fact that the ethical approval for the tumor xenograft experiments performed in mice, as shown in Fig. 7, had not been obtained from their hospital; consequently, all authors were in agreement that the article should be retracted to ensure the integrity of the scholarly record. Independently of this request, it was also drawn to the Editor&#x0027;s attention by a concerned reader that data in several of the figures were strikingly similar to data appearing in different form in other articles by different authors.</p>
<p>Owing to the fact that there were contentious data in the above article that had already been published prior to its submission to <italic>Oncology Reports</italic>, and after assessing the authors&#x0027; request, the Editor concurs that this paper should be retracted from the Journal. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
